New research published in JAMA Network Open finds that mailing human papillomavirus (HPV) self-sampling kits to patients is a cost-effective strategy for increasing cervical cancer screening completion rates. Long-term infection with high-risk HPV strains can cause abnormal cell growth, which could progress to cervical cancer. The study is the first to examine the cost-effectiveness of these mailing strategies across different patient screening histories within a U.S.-based health system.
This article was originally published on MedicalXpress.com
